We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$100M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$97M
3
LRCX icon
Lam Research
LRCX
+$85.4M
4
BSX icon
Boston Scientific
BSX
+$79.4M
5
MRK icon
Merck
MRK
+$67M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIGL icon
351
Rigel Pharmaceuticals
RIGL
$748M
$2.46M 0.04%
+82,366
New +$2.23M
FVT
352
DELISTED
Fortress Value Acquisition Corp. III
FVT
$2.46M 0.04%
249,688
– –
CCVI
353
DELISTED
Churchill Capital Corp VI
CCVI
$2.46M 0.04%
250,000
– –
MVLA
354
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$2.45M 0.04%
250,000
– –
HERA
355
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$2.45M 0.04%
250,000
– –
TWOA
356
DELISTED
two
TWOA
$2.44M 0.04%
250,000
– –
TETC
357
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
$2.44M 0.04%
250,000
– –
BSLK
358
DELISTED
Bolt Projects Holdings
BSLK
$2.44M 0.04%
12,500
– –
AFAQ
359
DELISTED
AF Acquisition Corp
AFAQ
$2.44M 0.04%
250,000
– –
PHR icon
360
Phreesia
PHR
$779M
$2.38M 0.04%
90,183
+84,606
+1,517% +$2.59M
MGNX icon
361
MacroGenics
MGNX
$250M
$2.37M 0.04%
269,272
– –
SEEL
362
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$2.35M 0.04%
730
-324
-31% -$1.39M
EPIX
363
DELISTED
ESSA Pharma
EPIX
$2.32M 0.04%
375,084
-309,163
-45% -$2.72M
DNTH icon
364
Dianthus Therapeutics
DNTH
$6.02B
$2.31M 0.04%
49,779
+33,249
+201% +$1.82M
ANTX icon
365
AN2 Therapeutics
ANTX
$212M
$2.26M 0.04%
+150,000
New +$2.28M
RCKT icon
366
Rocket Pharmaceuticals
RCKT
$381M
$2.25M 0.04%
+142,011
New +$2.45M
BRDG
367
DELISTED
Bridge Investment Group
BRDG
$2.23M 0.04%
109,496
-68,152
-38% -$1.43M
TPTX
368
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2.23M 0.04%
82,856
-17,788
-18% -$598K
BNAI
369
Brand Engagement Network
BNAI
$97.7M
$2.21M 0.04%
22,500
– –
VEEA
370
Veea Inc
VEEA
$8.71M
$2.2M 0.04%
225,000
– –
AMPI
371
DELISTED
Advanced Merger Partners Inc
AMPI
$2.2M 0.04%
225,000
– –
MIT
372
DELISTED
Mason Industrial Technology, Inc.
MIT
$2.15M 0.03%
220,000
– –
DNZ
373
DELISTED
D and Z Media Acquisition Corp.
DNZ
$2.14M 0.03%
218,990
– –
EXFY icon
374
Expensify
EXFY
$259M
$2.07M 0.03%
117,996
– –
TRML
375
DELISTED
Tourmaline Bio
TRML
$2.03M 0.03%
20,606
– –
13 14
15
16 17

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.